Evidence map›Paper›PMID 40123673›Full record

ArticleFrontiers in pediatrics2025

Advancing risk factor identification for pediatric lobar pneumonia: the promise of machine learning technologies.

Li Shen, Jiaqiang Wu, Min Lu, Yiguo Jiang, Xiaolan Zhang, Qiuyan Xu, Shuangqin Ran

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. A potential XGBoost Diagnostic Score forFrontiers in immunology · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li Shen *Department of Pharmacy, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.
Jiaqiang Wu *School of Life Sciences and Biopharmaceutical Science, Shenyang Pharmaceutical University, Shenyang, China.
Min LuDepartment of Pediatric, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.
Yiguo JiangDepartment of Pharmacy, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.
Xiaolan ZhangDepartment of Pharmacy, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.
Qiuyan XuDepartment of Pediatric, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.
Shuangqin RanDepartment of Pediatric, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community-acquired pneumonia (CAP) is a prevalent pediatric condition, and lobar pneumonia (LP) is considered a severe subtype. Early identification of LP is crucial for appropriate management. This study aimed to develop and compare machine learning models to predict LP in children with CAP. Methods: A total of 25 clinical and laboratory variables were collected. Missing data (<2%) were imputed, and the dataset was split into training (60%) and validation (40%) sets. Univariable logistic regression and Boruta feature selection were used to identify significant predictors. Four machine learning algorithms-Logistic Regression (LR), Support Vector Machine (SVM), Extreme Gradient Boosting (XGBoost), and Decision Tree (DT)-were compared using area under the curve (AUC), balanced accuracy, sensitivity, specificity, and F1 score. SHAP analysis was performed to interpret the best-performing model. Results: A total of 278 patients with CAP were included in this study, of whom 65 were diagnosed with LP. The XGBoost model demonstrated the best performance with an AUC of 0.880 (95% CI: 0.807-0.934) in the training set and 0.746 (95% CI: 0.664-0.843) in the validation set. SHAP analysis identified age, CRP, CD64 index, lymphocyte percentage, and ALB as the top five predictive factors. Conclusion: The XGBoost model showed superior performance in predicting LP in children with CAP. The model enabled early diagnosis and risk assessment of LP, thereby facilitating appropriate clinical decision-making.

Indexed as

lobar pneumoniamachine learningpediatricrisk factorXGBoost

Identifiers

PMID40123673
PMCPMC11925904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.